Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
15 results
D3.70 - Structural and immunological insights into arginine kinases from house dust mites and related arthropods
D3.63 - Molecular Evidence of PR-10 in Cannabis Allergy
D3.64 - Alcohol-Soluble Wheat Proteins as the Likely Allergenic Trigger in a Patient With Reaction to Gin
D3.66 - When dermatitis follows the menstrual cycle: two cases of endogenous progestogen hypersensitivity
D3.67 - Retrospective Evaluation of IgE Panel Utility in Allergy Diagnostics: Insights from Baghdad, Iraq
D3.71 - A research tool for development of in-house specific IgE immunoassays - comparison between different methods
D3.73 - Clinical Performance of Hycor NOVEOS–Based Specific IgE Measurements for the Screening of Respiratory Allergies
D3.74 - Age-related characteristics of children's sensitisation to timothy grass according to component diagnostics
D3.76 - Open-Label Clinical Trial To Evaluate The Effect Of Intranasal Olopatadine/Mometasone And Azelastine/Mometasone On Histamine Reactivity In Skin Prick Tests
D3.77 - Tattoo Ink Allergy? Diagnostic Challenges in Cutaneous Reactions to Tattoo Ink Containing Metals
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry
D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma
Download the app
The congress at your fingertips
Available on
Download